倾向评分校正比较机器人、胸腔镜与开胸肺叶切除术对非小细胞肺癌病理淋巴结升期的差异
该回顾性多中心研究纳入1053例临床N0/N1非小细胞肺癌患者,采用逆概率加权倾向评分校正后比较机器人、胸腔镜与开胸肺叶切除术的淋巴结升期率。胸腔镜升期风险低于开胸(OR 0.50),机器人则与开胸相似。
要点
- 开胸肺叶切除总体淋巴结升期率21.8%,高于机器人16.2%和胸腔镜12.3%。
- 纵隔N2升期率三组相似(开胸6.9%、机器人6.3%、胸腔镜4.4%)。
- 胸腔镜总体升期风险低于开胸(OR 0.50),机器人则与开胸相似。
核心结论
- 临床N0/N1非小细胞肺癌肺叶切除后病理淋巴结升期率仍较高。
- 与开胸相比,机器人肺叶切除总体升期率相似,胸腔镜则较低。
- 三组纵隔N2升期率无显著差异。
研究设计与样本
- 回顾性分析2中心2011至2018年1053例临床N0/N1非小细胞肺癌肺叶切除患者。
- 采用逆概率加权倾向评分校正基线特征,校正后分析纳入911例(机器人254、胸腔镜296、开胸261)。
- 主要终点为淋巴结升期。
主要发现
- 多因素分析:胸腔镜对比开胸淋巴结升期OR 0.50(95%CI 0.29-0.85),机器人对比开胸OR 0.72(95%CI 0.44-1.18)。
临床怎么用
- 应重视肺门和纵隔淋巴结的彻底评估以准确分期并发现隐匿转移。
- 胸腔镜肺叶切除可能总体淋巴结升期率较低,需关注其分期准确性。
局限性
- 回顾性研究设计,尽管采用倾向评分校正,仍可能存在未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the effectiveness of intraoperative lymph node (LN) staging by comparing upstaging between robotic-assisted surgery, video-assisted thoracoscopic surgery (VATS), and open thoracotomy approach for lobectomy for non-small cell lung cancer. METHODS: We retrospectively analyzed 1053 patients with clinical stage N0/N1 non-small cell lung cancer who underwent lobectomy at 2 centers between 2011 and 2018. Propensity score adjustment by inverse probability of treatment weighting was used to balance baseline characteristics. The primary end point was LN upstaging. RESULTS: A total of 911 patients (254 robotic, 296 VATS, and 261 open) were included in the inverse probability of treatment weighting adjusted analysis. The overall rate of LN upstaging was highest with open lobectomy (21.8%), followed by robotic (16.2%), and VATS (12.3%) (P = .03). Mediastinal N2 upstaging was observed in similar frequencies (open 6.9% vs robotic 6.3% vs VATS 4.4%; P = .6). No differences were seen for total LN counts, but were observed in the number of stations sampled (mean, open 4.0 vs robotic 3.8 vs VATS 3.6; P = .001). On multivariate analysis, LN upstaging was lower for VATS compared with open (odds ratio, 0.50; 95% confidence interval, 0.29-0.85), but not different between robotic and open (odds ratio, 0.72; 95% confidence interval, 0.44-1.18). No significant differences were seen in mediastinal N2 upstaging between groups. CONCLUSIONS: Pathologic LN upstaging following lobectomy for clinically N0/N1 NSCLC remains high. Compared with a traditional thoracotomy approach, robotic lobectomy was associated with similar and VATS with lower overall nodal upstaging. A thorough evaluation of hilar and mediastinal LNs remains critical to ensure accurate staging by detection of occult LN metastases.
引用
- Kneuertz PJ, Cheufou DH, D'Souza DM, et al. Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019. PMID: 31623811. doi:10.1016/j.jtcvs.2019.06.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。